The Bioequivalence Study of Lamotrigine Dispersible/Chewable Tablets 5mg×5 Compared With Lamotrigine Compressed Tablet 25mg in Chinese Healthy Male Subjects

NCT01879423 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Epilepsy

Interventions

DRUG: Lamotrigine Dispersible/Chewable tablets 5mg*5
DRUG: Lamotrigine Compressed tablet 25mg

Sponsor

GlaxoSmithKline